{"altmetric_id":829600,"counts":{"readers":{"mendeley":31,"citeulike":0,"connotea":0},"facebook":{"unique_users_count":1,"unique_users":["138343829568207"],"posts_count":1},"total":{"posts_count":3},"twitter":{"unique_users_count":2,"unique_users":["MDAMelanomaOnc","CancerCureNow"],"posts_count":2}},"citation":{"abstract":"T-cell receptor (TCR) variable V\u03b1 and V\u03b2 gene diversity is a surrogate biomarker for the therapeutic potential of adoptive immunotherapy and cellular immunity. Therefore, creating a straightforward, rapid, sensitive, and reliable method to view the global changes of both TCRV\u03b1 and V\u03b2 transcripts in heterogeneous populations of T cells is appealing.","abstract_source":"pubmed","altmetric_jid":"4f6fa6113cf058f610006efa","authors":["Zhang M","Maiti S","Bernatc C","Huls H","Rabinovich B","Champlin RE","Vence LM","Hwu P","Radvanyi LG","Cooper L","M. Zhang","S. Maiti","C. Bernatchez","H. Huls","B. Rabinovich","R. E. Champlin","L. M. Vence","P. Hwu","L. Radvanyi","L. J. N. Cooper"],"doi":"10.1158\/1078-0432.ccr-11-3234","endpage":"4742","first_seen_on":"2012-07-09T20:49:44+00:00","funders":["nci"],"issns":["1078-0432","1557-3265"],"issue":"17","journal":"Clinical Cancer Research","last_mentioned_on":1344598183,"links":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22761473"],"pmid":"22761473","pubdate":"2012-07-06T00:00:00+00:00","publisher_subjects":[{"name":"Oncology And Carcinogenesis","scheme":"era"}],"scopus_subjects":["Health Sciences","Medicine","Life Sciences","Biochemistry, Genetics and Molecular Biology"],"startpage":"4733","subjects":["neoplasms"],"title":"A new approach to simultaneously quantify both TCR \u03b1- and \u03b2-chain diversity after adoptive immunotherapy.","type":"article","uri":"http:\/\/clincancerres.aacrjournals.org\/cgi\/doi\/10.1158\/1078-0432.CCR-11-3234","volume":"18","mendeley_url":"http:\/\/www.mendeley.com\/research\/new-approach-simultaneously-quantify-both-tcr-chain-diversity-after-adoptive-immunotherapy"},"altmetric_score":{"score":1,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":1},"context_for_score":{"all":{"total_number_of_other_articles":4506762,"mean":5.1233691071599,"rank":2324746,"this_scored_higher_than_pct":34,"this_scored_higher_than":1543962,"rank_type":"exact","sample_size":4506762,"percentile":34},"similar_age_3m":{"total_number_of_other_articles":75492,"mean":5.0730971109139,"rank":35256,"this_scored_higher_than_pct":39,"this_scored_higher_than":29452,"rank_type":"exact","sample_size":75492,"percentile":39},"this_journal":{"total_number_of_other_articles":3978,"mean":3.7730203671109,"rank":2498,"this_scored_higher_than_pct":21,"this_scored_higher_than":874,"rank_type":"exact","sample_size":3978,"percentile":21},"similar_age_this_journal_3m":{"total_number_of_other_articles":25,"mean":1.5041666666667,"rank":14,"this_scored_higher_than_pct":20,"this_scored_higher_than":5,"rank_type":"exact","sample_size":25,"percentile":20}}},"demographics":{"poster_types":{"member_of_the_public":1,"practitioner":1},"users":{"twitter":{"cohorts":{"Practitioners (doctors, other healthcare professionals)":1,"Members of the public":1}},"mendeley":{"by_status":{"Professor > Associate Professor":2,"Researcher":6,"Student  > Doctoral Student":1,"Student  > Ph. D. Student":13,"Student  > Postgraduate":1,"Other":3,"Student  > Bachelor":4,"Professor":1},"by_discipline":{"Medicine and Dentistry":7,"Immunology and Microbiology":3,"Agricultural and Biological Sciences":15,"Biochemistry, Genetics and Molecular Biology":5,"Pharmacology, Toxicology and Pharmaceutical Science":1}}},"geo":{"twitter":{"US":1},"mendeley":{"NL":2,"US":1,"JP":1,"CN":1}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/MDAMelanomaOnc\/statuses\/222432209397760000","license":"public","citation_ids":[829600],"posted_on":"2012-07-09T20:49:05+00:00","author":{"name":"Melanoma Medical Onc","url":"http:\/\/bit.ly\/YJqC93","image":"https:\/\/pbs.twimg.com\/profile_images\/876835879158927360\/64tmhrsw_normal.jpg","description":"Melanoma news from the Melanoma Medical Oncology Department at world-renowned MD Anderson Cancer Center; phone 877-632-6789","id_on_source":"MDAMelanomaOnc","tweeter_id":"281225020","geo":{"lt":29.76328,"ln":-95.36327,"country":"US"},"followers":3112},"tweet_id":"222432209397760000"},{"url":"http:\/\/twitter.com\/#!\/CancerCureNow\/status\/233887850326814722","citation_ids":[829600],"posted_on":"2012-08-10T11:29:43+00:00","author":{"name":"Cure Cancer Now","url":"http:\/\/cancercure-d.blogspot.com\/","image":"https:\/\/pbs.twimg.com\/profile_images\/1128872809\/Hep_G2_Lab_test_normal.jpg","description":"Pure science is what it is taking to defeat cancer. Follow us to be a part of history in the making. Receive only the best information here.","id_on_source":"CancerCureNow","tweeter_id":"193691326","geo":{"lt":null,"ln":null},"followers":8381},"tweet_id":"233887850326814722"}],"facebook":[{"title":"A new approach to simultaneously quantify bo... [Clin Cancer Res. 2012] - PubMed - NCBI","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=132080216931798&id=138343829568207","citation_ids":[829600],"posted_on":"2012-07-09T20:49:04+00:00","summary":"MDAnderson Melanoma's Radvanyi & co devise direct TCR expression assay for use after adoptive immunotherapy \nhttp:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22761473","author":{"name":"Melanoma Medical Oncology at MD Anderson","url":"https:\/\/www.facebook.com\/138343829568207","facebook_wall_name":"Melanoma Medical Oncology at MD Anderson","image":"https:\/\/graph.facebook.com\/138343829568207\/picture","id_on_source":"138343829568207"}}]}}